{
    "organizations": [],
    "uuid": "9a30513fd1304124d4ef2b9daf07aa15790e7550",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fda-says-making-list-of-cos-blocki/brief-fda-says-making-list-of-cos-blocking-access-to-samples-of-branded-products-idUSFWN1SO0V0",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Says Making List Of Cos Blocking Access To Samples Of Branded Products",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 17 (Reuters) - FDA:\n* FDA COMMISSIONER SCOTT GOTTLIEB SAYS MAKING PUBLIC LIST OF COS THAT HAVE POTENTIALLY BEEN BLOCKING ACCESS TO THE SAMPLES OF THEIR BRANDED PRODUCTS\n* FDA’S GOTTLIEB - ALSO NOTIFYING FEDERAL TRADE COMMISSION ABOUT INQUIRIES RECEIVED FROM GENERIC DRUG DEVELOPERS\n* FDA’S GOTTLIEB - FDA WILL DETERMINE WHETHER THE PRODUCTS HAVE IN PLACE RISK EVALUATION & MITIGATION STRATEGY PROGRAM WITH ETASU THAT MAY IMPACT DISTRIBUTION\n* FDA’S GOTTLIEB SAYS IN MANY CASES, WE FIND THAT THERE’S NO SUCH REMS PROGRAM IN PLACE\n* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE NOVARTIS PHARMA, ACTELION PHARMA, VALEANT, SMITHKLINE BEECHAM, GILEAD, CELGENE\n* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE BIOGEN IDEC, INSYS THERAPEUTICS, LUNDBECK LLC, HYPERION THERAPEUTICS, VIVUS INC\n* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE PFIZER PHARMACEUTICALS PRODUCTION, SWEDISH ORPHAN BIOVITRUM, MEDA PHARMA\n* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE DANCO LABORATORIES, ROXANE LABORATORIES, CORCEPT THERAPEUTICS, AEGERION PHARMA\n* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE PHARMACIA AND UPJOHN CO, QUESTCOR PHARMACEUTICALS, BOEHRINGER INGELHEIM, NPS PHARMA\n* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE SHIRE ORPHAN THERAPIES, APOPHARMA, CEPHALON INC, JAZZ PHARMA, CUBIST PHARMA\n* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE TEVA PHARMA USA, ALPHARMA PHARMA, ORPHAN EUROPE SARL, HERITAGE LIFE SCIENCES\n* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE ASTRAZENECA LP, ACORDA THERAPEUTICS, MYLAN PHARMA, NOVARTIS PHARMA\n* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE BAYER HEALTHCARE PHARMA, ROCHE PALO ALTO, GALENA BIOPHARMA\n* FDA'S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE RANBAXY INC/SUN PHARMACEUTICAL INDUSTRIES INC Source text : ( bit.ly/2rRalSM ) Further company coverage:\n ",
    "published": "2018-05-17T22:33:00.000+03:00",
    "crawled": "2018-05-18T19:43:31.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "fda",
        "fda",
        "commissioner",
        "scott",
        "gottlieb",
        "say",
        "making",
        "public",
        "list",
        "co",
        "potentially",
        "blocking",
        "access",
        "sample",
        "branded",
        "product",
        "fda",
        "gottlieb",
        "also",
        "notifying",
        "federal",
        "trade",
        "commission",
        "inquiry",
        "received",
        "generic",
        "drug",
        "developer",
        "fda",
        "gottlieb",
        "fda",
        "determine",
        "whether",
        "product",
        "place",
        "risk",
        "evaluation",
        "mitigation",
        "strategy",
        "program",
        "etasu",
        "may",
        "impact",
        "distribution",
        "fda",
        "gottlieb",
        "say",
        "many",
        "case",
        "find",
        "rem",
        "program",
        "place",
        "fda",
        "gottlieb",
        "co",
        "inquiry",
        "received",
        "include",
        "novartis",
        "pharma",
        "actelion",
        "pharma",
        "valeant",
        "smithkline",
        "beecham",
        "gilead",
        "celgene",
        "fda",
        "gottlieb",
        "co",
        "inquiry",
        "received",
        "include",
        "biogen",
        "idec",
        "insys",
        "therapeutic",
        "lundbeck",
        "llc",
        "hyperion",
        "therapeutic",
        "vivus",
        "inc",
        "fda",
        "gottlieb",
        "co",
        "inquiry",
        "received",
        "include",
        "pfizer",
        "pharmaceutical",
        "production",
        "swedish",
        "orphan",
        "biovitrum",
        "meda",
        "pharma",
        "fda",
        "gottlieb",
        "co",
        "inquiry",
        "received",
        "include",
        "danco",
        "laboratory",
        "roxane",
        "laboratory",
        "corcept",
        "therapeutic",
        "aegerion",
        "pharma",
        "fda",
        "gottlieb",
        "co",
        "inquiry",
        "received",
        "include",
        "pharmacia",
        "upjohn",
        "co",
        "questcor",
        "pharmaceutical",
        "boehringer",
        "ingelheim",
        "np",
        "pharma",
        "fda",
        "gottlieb",
        "co",
        "inquiry",
        "received",
        "include",
        "shire",
        "orphan",
        "therapy",
        "apopharma",
        "cephalon",
        "inc",
        "jazz",
        "pharma",
        "cubist",
        "pharma",
        "fda",
        "gottlieb",
        "co",
        "inquiry",
        "received",
        "include",
        "teva",
        "pharma",
        "usa",
        "alpharma",
        "pharma",
        "orphan",
        "europe",
        "sarl",
        "heritage",
        "life",
        "science",
        "fda",
        "gottlieb",
        "co",
        "inquiry",
        "received",
        "include",
        "astrazeneca",
        "lp",
        "acorda",
        "therapeutic",
        "mylan",
        "pharma",
        "novartis",
        "pharma",
        "fda",
        "gottlieb",
        "co",
        "inquiry",
        "received",
        "include",
        "bayer",
        "healthcare",
        "pharma",
        "roche",
        "palo",
        "alto",
        "galena",
        "biopharma",
        "fda",
        "gottlieb",
        "co",
        "inquiry",
        "received",
        "include",
        "ranbaxy",
        "pharmaceutical",
        "industry",
        "inc",
        "source",
        "text",
        "company",
        "coverage"
    ]
}